List of Tables
Table 1. Global Primary Antibodies and Reagents Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Polyclonal
Table 3. Key Players of Monoclonal
Table 4. Global Primary Antibodies and Reagents Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Primary Antibodies and Reagents Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Primary Antibodies and Reagents Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Primary Antibodies and Reagents Market Share by Region (2020-2025)
Table 8. Global Primary Antibodies and Reagents Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Primary Antibodies and Reagents Market Share by Region (2026-2031)
Table 10. Primary Antibodies and Reagents Market Trends
Table 11. Primary Antibodies and Reagents Market Drivers
Table 12. Primary Antibodies and Reagents Market Challenges
Table 13. Primary Antibodies and Reagents Market Restraints
Table 14. Global Primary Antibodies and Reagents Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Primary Antibodies and Reagents Market Share by Players (2020-2025)
Table 16. Global Top Primary Antibodies and Reagents Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Primary Antibodies and Reagents as of 2024)
Table 17. Ranking of Global Top Primary Antibodies and Reagents Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Primary Antibodies and Reagents Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Primary Antibodies and Reagents, Headquarters and Area Served
Table 20. Global Key Players of Primary Antibodies and Reagents, Product and Application
Table 21. Global Key Players of Primary Antibodies and Reagents, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Primary Antibodies and Reagents Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Primary Antibodies and Reagents Revenue Market Share by Type (2020-2025)
Table 25. Global Primary Antibodies and Reagents Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Primary Antibodies and Reagents Revenue Market Share by Type (2026-2031)
Table 27. Global Primary Antibodies and Reagents Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Primary Antibodies and Reagents Revenue Market Share by Application (2020-2025)
Table 29. Global Primary Antibodies and Reagents Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Primary Antibodies and Reagents Revenue Market Share by Application (2026-2031)
Table 31. North America Primary Antibodies and Reagents Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Primary Antibodies and Reagents Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Primary Antibodies and Reagents Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Primary Antibodies and Reagents Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Primary Antibodies and Reagents Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Primary Antibodies and Reagents Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Primary Antibodies and Reagents Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Primary Antibodies and Reagents Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Primary Antibodies and Reagents Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Primary Antibodies and Reagents Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Primary Antibodies and Reagents Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Primary Antibodies and Reagents Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Primary Antibodies and Reagents Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Primary Antibodies and Reagents Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Primary Antibodies and Reagents Market Size by Country (2026-2031) & (US$ Million)
Table 46. Bio-Rad Company Details
Table 47. Bio-Rad Business Overview
Table 48. Bio-Rad Primary Antibodies and Reagents Product
Table 49. Bio-Rad Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 50. Bio-Rad Recent Development
Table 51. Rockland Immunochemicals Company Details
Table 52. Rockland Immunochemicals Business Overview
Table 53. Rockland Immunochemicals Primary Antibodies and Reagents Product
Table 54. Rockland Immunochemicals Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 55. Rockland Immunochemicals Recent Development
Table 56. Biorbyt Company Details
Table 57. Biorbyt Business Overview
Table 58. Biorbyt Primary Antibodies and Reagents Product
Table 59. Biorbyt Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 60. Biorbyt Recent Development
Table 61. Agilent Company Details
Table 62. Agilent Business Overview
Table 63. Agilent Primary Antibodies and Reagents Product
Table 64. Agilent Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 65. Agilent Recent Development
Table 66. SouthernBiotech Company Details
Table 67. SouthernBiotech Business Overview
Table 68. SouthernBiotech Primary Antibodies and Reagents Product
Table 69. SouthernBiotech Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 70. SouthernBiotech Recent Development
Table 71. Proteintech Company Details
Table 72. Proteintech Business Overview
Table 73. Proteintech Primary Antibodies and Reagents Product
Table 74. Proteintech Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 75. Proteintech Recent Development
Table 76. Elabscience Company Details
Table 77. Elabscience Business Overview
Table 78. Elabscience Primary Antibodies and Reagents Product
Table 79. Elabscience Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 80. Elabscience Recent Development
Table 81. Abcam Company Details
Table 82. Abcam Business Overview
Table 83. Abcam Primary Antibodies and Reagents Product
Table 84. Abcam Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 85. Abcam Recent Development
Table 86. BD Company Details
Table 87. BD Business Overview
Table 88. BD Primary Antibodies and Reagents Product
Table 89. BD Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 90. BD Recent Development
Table 91. Santa Cruz Biotechnology Company Details
Table 92. Santa Cruz Biotechnology Business Overview
Table 93. Santa Cruz Biotechnology Primary Antibodies and Reagents Product
Table 94. Santa Cruz Biotechnology Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 95. Santa Cruz Biotechnology Recent Development
Table 96. Sigma Aldrich Corporation Company Details
Table 97. Sigma Aldrich Corporation Business Overview
Table 98. Sigma Aldrich Corporation Primary Antibodies and Reagents Product
Table 99. Sigma Aldrich Corporation Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 100. Sigma Aldrich Corporation Recent Development
Table 101. Thermo Fisher Scientific Company Details
Table 102. Thermo Fisher Scientific Business Overview
Table 103. Thermo Fisher Scientific Primary Antibodies and Reagents Product
Table 104. Thermo Fisher Scientific Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 105. Thermo Fisher Scientific Recent Development
Table 106. Abnova Company Details
Table 107. Abnova Business Overview
Table 108. Abnova Primary Antibodies and Reagents Product
Table 109. Abnova Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 110. Abnova Recent Development
Table 111. R&D Systems Company Details
Table 112. R&D Systems Business Overview
Table 113. R&D Systems Primary Antibodies and Reagents Product
Table 114. R&D Systems Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 115. R&D Systems Recent Development
Table 116. MBL Company Details
Table 117. MBL Business Overview
Table 118. MBL Primary Antibodies and Reagents Product
Table 119. MBL Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 120. MBL Recent Development
Table 121. CST Company Details
Table 122. CST Business Overview
Table 123. CST Primary Antibodies and Reagents Product
Table 124. CST Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 125. CST Recent Development
Table 126. Merk Company Details
Table 127. Merk Business Overview
Table 128. Merk Primary Antibodies and Reagents Product
Table 129. Merk Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 130. Merk Recent Development
Table 131. Novus Biologicals Company Details
Table 132. Novus Biologicals Business Overview
Table 133. Novus Biologicals Primary Antibodies and Reagents Product
Table 134. Novus Biologicals Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 135. Novus Biologicals Recent Development
Table 136. PeproTech Company Details
Table 137. PeproTech Business Overview
Table 138. PeproTech Primary Antibodies and Reagents Product
Table 139. PeproTech Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 140. PeproTech Recent Development
Table 141. Cayman Company Details
Table 142. Cayman Business Overview
Table 143. Cayman Primary Antibodies and Reagents Product
Table 144. Cayman Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 145. Cayman Recent Development
Table 146. AbMax Biotechnology Company Details
Table 147. AbMax Biotechnology Business Overview
Table 148. AbMax Biotechnology Primary Antibodies and Reagents Product
Table 149. AbMax Biotechnology Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 150. AbMax Biotechnology Recent Development
Table 151. MABTech Company Details
Table 152. MABTech Business Overview
Table 153. MABTech Primary Antibodies and Reagents Product
Table 154. MABTech Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 155. MABTech Recent Development
Table 156. KPL Company Details
Table 157. KPL Business Overview
Table 158. KPL Primary Antibodies and Reagents Product
Table 159. KPL Revenue in Primary Antibodies and Reagents Business (2020-2025) & (US$ Million)
Table 160. KPL Recent Development
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
Table 164. Authors List of This Report
List of Figures
Figure 1. Primary Antibodies and Reagents Picture
Figure 2. Global Primary Antibodies and Reagents Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Primary Antibodies and Reagents Market Share by Type: 2024 VS 2031
Figure 4. Polyclonal Features
Figure 5. Monoclonal Features
Figure 6. Global Primary Antibodies and Reagents Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Primary Antibodies and Reagents Market Share by Application: 2024 VS 2031
Figure 8. ELISA Case Studies
Figure 9. Western Blot Case Studies
Figure 10. Immunostaining Case Studies
Figure 11. Immunohistochemistry Case Studies
Figure 12. Immunocytochemistry Case Studies
Figure 13. Other Case Studies
Figure 14. Primary Antibodies and Reagents Report Years Considered
Figure 15. Global Primary Antibodies and Reagents Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Primary Antibodies and Reagents Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Primary Antibodies and Reagents Market Share by Region: 2024 VS 2031
Figure 18. Global Primary Antibodies and Reagents Market Share by Players in 2024
Figure 19. Global Top Primary Antibodies and Reagents Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Primary Antibodies and Reagents as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Primary Antibodies and Reagents Revenue in 2024
Figure 21. North America Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Primary Antibodies and Reagents Market Share by Country (2020-2031)
Figure 23. United States Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Primary Antibodies and Reagents Market Share by Country (2020-2031)
Figure 27. Germany Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Primary Antibodies and Reagents Market Share by Region (2020-2031)
Figure 35. China Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Primary Antibodies and Reagents Market Share by Country (2020-2031)
Figure 43. Mexico Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Primary Antibodies and Reagents Market Share by Country (2020-2031)
Figure 47. Turkey Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Primary Antibodies and Reagents Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Bio-Rad Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 51. Rockland Immunochemicals Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 52. Biorbyt Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 53. Agilent Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 54. SouthernBiotech Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 55. Proteintech Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 56. Elabscience Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 57. Abcam Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 58. BD Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 59. Santa Cruz Biotechnology Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 60. Sigma Aldrich Corporation Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 61. Thermo Fisher Scientific Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 62. Abnova Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 63. R&D Systems Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 64. MBL Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 65. CST Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 66. Merk Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 67. Novus Biologicals Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 68. PeproTech Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 69. Cayman Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 70. AbMax Biotechnology Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 71. MABTech Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 72. KPL Revenue Growth Rate in Primary Antibodies and Reagents Business (2020-2025)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
